


New York’s healthcare providers are operating within an increasingly constrained fiscal environment. Rising costs for supplies, capital investments, and labor continue to outpace reimbursement growth. As the implications of the Federal H.R. 1 loom over the state’s fiscal outlook, the focus is shifting from identifying cost pressures to determining how the healthcare system can adapt while preserving access and stability.
H.R. 1 marks a pivotal shift in the federal approach to healthcare financing. With greater responsibility moving to states, providers, and patients, Medicaid programs—which do not fully cover the cost of care—face renewed fiscal pressure. In this context, predictable and timely commercial reimbursement plays an increasingly important role in supporting essential services across the healthcare continuum.
At the same time, health insurers—facing rising utilization and cost pressures—continue to leverage tools like prior authorization, utilization review, and payment integrity programs to manage care and control expenditures. The expanded use of these tools has introduced administrative burden and financial uncertainty for providers, especially when decisions are delayed, reversed, or hard to contest.
These challenges have broader policy implications. Financial stress on hospitals and health systems can lead to deferred infrastructure upgrades, workforce instability, and service reductions—particularly in underserved areas. As provider instability grows, states may face mounting costs and increased pressure to intervene.
This is not an argument against insurer oversight. Health plans have a responsibility to manage resources on behalf of employers, taxpayers, and premium payers. Yet, state policy has an important role to play in ensuring these oversight practices are transparent, clinically grounded, and implemented in ways that protect timely care and system stability.
As federal support recedes, strategic coordination among providers, payers, and policymakers will become increasingly vital. Balanced, experienced engagement can help shape policy solutions that weigh cost control with access, accountability, and long-term sustainability throughout New York’s healthcare system.
Ostroff Associates partners with healthcare stakeholders to navigate these shifting dynamics and shape policies that strengthen long-term system stability. Our team brings the experience needed to mitigate risk, protect your interests, and support thoughtful engagement in a rapidly evolving healthcare environment.
How is H.R. 1 affecting New York healthcare providers?
New York's healthcare providers are operating in an increasingly constrained fiscal environment following the enactment of H.R. 1, the federal reconciliation bill with significant implications for Medicaid financing, provider payments, and program eligibility. Providers across the state are navigating new reimbursement pressures, compliance expectations, and long-term planning questions that the law has introduced.
What should New York healthcare providers prioritize in their government relations strategy after H.R. 1?
Healthcare providers should prioritize active engagement with the New York State budget process, direct tracking of federal CMS guidance and enforcement, clear documentation of operational and financial impact from reduced reimbursement, and coordinated advocacy through provider associations and government affairs partners to shape state-level responses to federal changes.
Does Ostroff Associates represent healthcare clients in New York?
Yes. Healthcare is one of Ostroff Associates' core practice areas. The firm represents health systems, behavioral health providers, long-term care operators, and other healthcare organizations in budget advocacy, regulatory engagement, and legislative strategy before New York State government. Senior Vice President Adam Mandel leads health policy work at the firm.